Published ahead of print on November 19, 2004, doi:10.1164/rccm.200406-808OC
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 242-248, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200406-808OC
Hydrocortisone Infusion for Severe Community-acquired Pneumonia
A Preliminary Randomized Study
Marco Confalonieri,
Rosario Urbino,
Alfredo Potena,
Marco Piattella,
Piercarlo Parigi,
Giacomo Puccio,
Rossana Della Porta,
Carbone Giorgio,
Francesco Blasi,
Reba Umberger and
G. Umberto Meduri
Ospedale di Trieste, Trieste; Ospedale Gradenigo-Torino; Ospedale Molinette di Torino; Arcispedale S. Anna di Ferrara; Ospedale di Crema; Ospedale di Paderno Dugnano-Milano; Institute of Respiratory Diseases, University of Milan, Milan, Italy; and Memphis Lung Research Program, Memphis, Tennessee
Correspondence and requests for reprints should be addressed to Dr. Marco Confalonieri, Azienda Ospedaliero-Universitaria di Trieste, Strada di Fiume 447, 34100 Trieste, Italy. E-mail: marco.confalonieri{at}aots.sanita.fvg.it
We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications. In a multicenter trial, patients admitted to the Intensive Care Unit (ICU) with severe community-acquired pneumonia received protocol-guided antibiotic treatment and were randomly assigned to hydrocortisone infusion or placebo. Hydrocortisone was given as an intravenous 200-mg bolus followed by infusion at a rate of 10 mg/hour for 7 days. Primary end-points of the study were improvement in PaO2:FIO2 (PaO2:FIO2 > 300 or 100 increase from study entry) and multiple organ dysfunction syndrome (MODS) score by Study Day 8 and reduction in delayed septic shock. Forty-six patients entered the study. At study entry, the hydrocortisone group had lower PaO2:FIO2, and higher chest radiograph score and C-reactive protein level. By Study Day 8, treated patients had, compared with control subjects, a significant improvement in PaO2:FIO2 (p = 0.002) and chest radiograph score (p < 0.0001), and a significant reduction in C-reactive protein levels (p = 0.01), MODS score (p = 0.003), and delayed septic shock (p = 0.001). Hydrocortisone treatment was associated with a significant reduction in length of hospital stay (p = 0.03) and mortality (p = 0.009).
Key Words: community-acquired pneumonia C-reactive protein hydrocortisone respiratory failure severe sepsis
This article has been cited by other articles:

|
 |

|
 |
 
Y.-C. Wu, P.-K. Hsu, K.-C. Su, L.-Y. Liu, C.-C. Tsai, S.-H. Tsai, W.-H. Hsu, Y.-C. Lee, and D.-W. Perng
Bile Acid Aspiration in Suspected Ventilator-Associated Pneumonia
Chest,
July 1, 2009;
136(1):
118 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Annane, E. Bellissant, P.-E. Bollaert, J. Briegel, M. Confalonieri, R. De Gaudio, D. Keh, Y. Kupfer, M. Oppert, and G. U. Meduri
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
JAMA,
June 10, 2009;
301(22):
2362 - 2375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Bornstein
Predisposing Factors for Adrenal Insufficiency
N. Engl. J. Med.,
May 28, 2009;
360(22):
2328 - 2339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Silva, C. S. N. B. Garcia, P. A. Maronas, V. R. Cagido, E. M. Negri, N. R. Damaceno-Rodrigues, G. M. Ventura, P. T. Bozza, W. A. Zin, V. L. Capelozzi, et al.
Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Eur. Respir. J.,
March 1, 2009;
33(3):
634 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Marik
Critical Illness-Related Corticosteroid Insufficiency
Chest,
January 1, 2009;
135(1):
181 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Diaz, E. M. Mortensen, A. Anzueto, and M. I. Restrepo
Review: Novel targets in the management of pneumonia
Therapeutic Advances in Respiratory Disease,
December 1, 2008;
2(6):
387 - 400.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. J. Kim, K. M. Pack, E. Jeong, J. O. Na, Y-M. Oh, S. D. Lee, W. S. Kim, D. S. Kim, W. D. Kim, and T. S. Shim
Pulmonary tuberculosis with acute respiratory failure
Eur. Respir. J.,
December 1, 2008;
32(6):
1625 - 1630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aliberti, A. Amir, P. Peyrani, M. Mirsaeidi, M. Allen, B. K. Moffett, J. Myers, F. Shaib, M. Cirino, J. Bordon, et al.
Incidence, Etiology, Timing, and Risk Factors for Clinical Failure in Hospitalized Patients With Community-Acquired Pneumonia
Chest,
November 1, 2008;
134(5):
955 - 962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. F. Salluh, F. A. Bozza, M. Soares, J. C. R. Verdeal, H. C. Castro-Faria-Neto, J. R. Lapa e Silva, and P. T. Bozza
Adrenal Response in Severe Community-Acquired Pneumonia: Impact on Outcomes and Disease Severity
Chest,
November 1, 2008;
134(5):
947 - 954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. I. Siempos, K. Z. Vardakas, P. Kopterides, and M. E. Falagas
Adjunctive therapies for community-acquired pneumonia: a systematic review
J. Antimicrob. Chemother.,
October 1, 2008;
62(4):
661 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sibila, C. M. Luna, C. Agusti, S. Baquero, S. Gando, J. R. Patron, J. G. Morato, R. Absi, N. Bassi, and A. Torres
Effects of glucocorticoids in ventilated piglets with severe pneumonia
Eur. Respir. J.,
October 1, 2008;
32(4):
1037 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Garcia-Vidal, N. Fernandez-Sabe, J. Carratala, V. Diaz, R. Verdaguer, J. Dorca, F. Manresa, and F. Gudiol
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Eur. Respir. J.,
September 1, 2008;
32(3):
733 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Sibila, C. Agusti, and A. Torres
Corticosteroids in severe pneumonia
Eur. Respir. J.,
August 1, 2008;
32(2):
259 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Annane, G. Umberto Meduri, and P. Marik
Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Eur. Respir. J.,
June 1, 2008;
31(6):
1150 - 1152.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gotoh, N. Nishimura, O. Takahashi, H. Shiratsuka, H. Horinouchi, H. Ono, N. Uchiyama, and N. Chohnabayashi
Adrenal function in patients with community-acquired pneumonia
Eur. Respir. J.,
June 1, 2008;
31(6):
1268 - 1273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. McGee and J. Hirschmann
Use of Corticosteroids in Treating Infectious Diseases
Arch Intern Med,
May 26, 2008;
168(10):
1034 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Peter, P. John, P. L Graham, J. L Moran, I. A. George, and A. Bersten
Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis
BMJ,
May 3, 2008;
336(7651):
1006 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Mizgerd
Acute Lower Respiratory Tract Infection
N. Engl. J. Med.,
February 14, 2008;
358(7):
716 - 727.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Garcia-Vidal, E. Calbo, V. Pascual, C. Ferrer, S. Quintana, and J. Garau
Effects of systemic steroids in patients with severe community-acquired pneumonia
Eur. Respir. J.,
November 1, 2007;
30(5):
951 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christ-Crain, D. Stolz, S. Jutla, O. Couppis, C. Muller, R. Bingisser, P. Schuetz, M. Tamm, R. Edwards, B. Muller, et al.
Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia
Am. J. Respir. Crit. Care Med.,
November 1, 2007;
176(9):
913 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Menendez and A. Torres
Treatment Failure in Community-Acquired Pneumonia
Chest,
October 1, 2007;
132(4):
1348 - 1355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Meduri
There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS
Chest,
September 1, 2007;
132(3):
1097 - 1100.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Meduri, P. E. Marik, S. M. Pastores, D. Annane, C. S. Calfee, and M. A. Matthay
Corticosteroids in ARDS: A Counterpoint
Chest,
September 1, 2007;
132(3):
1093 - 1094.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Thomas and G. L Fraser
An Update on the Diagnosis of Adrenal Insufficiency and the Use of Corticotherapy in Critical Illness
Ann. Pharmacother.,
September 1, 2007;
41(9):
1456 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kellum, L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy, M. R. Pinsky, J. Fine, A. Krichevsky, R. L. Delude, D. C. Angus, et al.
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study
Arch Intern Med,
August 13, 2007;
167(15):
1655 - 1663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K Gorman, R. S Slavik, and J. Marin
Corticosteroid Treatment of Severe Community-Acquired Pneumonia
Ann. Pharmacother.,
July 1, 2007;
41(7):
1233 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J.,
June 1, 2007;
29(6):
1224 - 1238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Annane
Glucocorticoids for ARDS: Just Do It!
Chest,
April 1, 2007;
131(4):
945 - 946.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Meduri, E. Golden, A. X. Freire, E. Taylor, M. Zaman, S. J. Carson, M. Gibson, and R. Umberger
Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial
Chest,
April 1, 2007;
131(4):
954 - 963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Niederman
Recent Advances in Community-Acquired Pneumonia: Inpatient and Outpatient
Chest,
April 1, 2007;
131(4):
1205 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Annane, V. Maxime, F. Ibrahim, J. C. Alvarez, E. Abe, and P. Boudou
Diagnosis of Adrenal Insufficiency in Severe Sepsis and Septic Shock
Am. J. Respir. Crit. Care Med.,
December 15, 2006;
174(12):
1319 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. F. Salluh and A. G. Fuks
Corticosteroids in Critically Ill Patients: A Long and Winding Road
Arch Surg,
September 1, 2006;
141(9):
945 - 945.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Marik, D. Annane, C. L. Sprung, W. Arlt, D. Keh, and for the International Task Force on the Diagnoses
Using Corticosteroids in Intensive Care
Arch Surg,
September 1, 2006;
141(9):
946 - 947.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Torres and R. Menendez
Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
Eur. Respir. J.,
August 1, 2006;
28(2):
262 - 263.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Jackson Jr.
Adrenal insufficiency and ventilator weaning: additional study is required.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1176 - 1176.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med.,
April 15, 2006;
173(8):
833 - 841.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Ho, H. Al-Musalhi, M. J. Chapman, T. Quach, P. D. Thomas, C. J. Bagley, J. G. Lewis, and D. J. Torpy
Septic Shock and Sepsis: A Comparison of Total and Free Plasma Cortisol Levels
J. Clin. Endocrinol. Metab.,
January 1, 2006;
91(1):
105 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Rivers, L. McIntyre, D. C. Morro, and K. K. Rivers
Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity
Can. Med. Assoc. J.,
October 25, 2005;
173(9):
1054 - 1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Other articles noted
Evid. Based Med.,
October 1, 2005;
10(5):
157 - 158.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Trow
Clinical Year in Review II: Pulmonary Infections, Diagnostic Imaging, Pleural Diseases, and Neuromuscular Disease
Proceedings of the ATS,
October 1, 2005;
2(3):
175 - 178.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Restrepo, L. F. Angel, E. M. Mortensen, and A. Anzueto
Steroid Infusion for Severe Pneumonia: Not so Fast...
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
781 - 781.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Meduri, R. Umberger, and M. Confalonieri
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: The Role of Relative Adrenal Insufficiency
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
782 - 783.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jalloul
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: The Role of Relative Adrenal Insufficiency
Am. J. Respir. Crit. Care Med.,
September 15, 2005;
172(6):
781 - 781.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Meduri and M. Confalonieri
"Stop Right There...I Gotta Know Right Now!" Do Steroids Really Help for CAP?
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
644 - 645.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nseir, C. Di Pompeo, S. Soubrier, B. Cavestri, E. Jozefowicz, F. Saulnier, and A. Durocher
Impact of Ventilator-Associated Pneumonia on Outcome in Patients With COPD
Chest,
September 1, 2005;
128(3):
1650 - 1656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wattanathum, S. Manocha, H. Groshaus, J. A. Russell, and K. R. Walley
Interleukin-10 Haplotype Associated With Increased Mortality in Critically Ill Patients With Sepsis From Pneumonia But Not in Patients With Extrapulmonary Sepsis
Chest,
September 1, 2005;
128(3):
1690 - 1698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Scales, N. D. Ferguson, and J. O. Friedrich
"Stop Right There...I Gotta Know Right Now!" Do Steroids Really Help for CAP?
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
643 - 644.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|